Cancer Therapy
Recent findings in cancer therapy described
Published in Respiratory Therapeutics Week, February 20th, 2006
Study 1: Gefitinib treats carcinomatous meningitis (CM) in a patient with lung cancer.
According to recent research from South Korea, "CM and spinal cord metastases (SCM) are uncommon, yet fatal complication for patients with non-small cell lung cancer (NSCLC). Gefitinib, developed to inhibit the tyrosine kinase of the epidermal growth factor receptor (EGFR), represents the first new treatment modality for NSCLC to emerge from the last decade."
"Furthermore, it is an attractive option for lung cancer patients with central nervous system...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
More Articles from Respiratory Therapeutics Week
- Asthma
Researchers to test new thermal energy procedure to reduce asthmatic symptoms - Chronic Lung Disease
Inhibiting EGFR and IL-13 production may reduce excess mucus production - Cystic Fibrosis
Common food preservative might provide treatment for cystic fibrosis - Medical Devices
Flu pandemic will pose tough choices for use of mechanical ventilation - Asthma
Pharma company signs distribution agreement for asthma management tool in Scandinavian countries - Asthma
Winter's cold can exacerbate asthma - More from this issue of Respiratory Therapeutics Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
